Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9FN3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $77,926
Award facts
- Contract value 100% obligated
- $77,925.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $77,925.76 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This non-competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. Dupixent is a biologic medication used to treat moderate-to-severe eczema, asthma, and other atopic conditions, making this delivery critical to military healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a prime vendor for federal medical procurement across the Defense Health Agency and other government healthcare systems. The company's comprehensive SPE2DX contract vehicle enables it to supply a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies globally to support military healthcare programs. This delivery order exemplifies the company's established capability to meet federal medical supply requirements on compressed timelines, consistent with its extensive portfolio of competitively awarded federal contracts ranging from small-value transactions to orders exceeding $45,000.
Quick answers
Who was awarded contract SPE2DR26F9FN3?
SPE2DR26F9FN3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F9FN3 worth?
The government has obligated $77,926 on SPE2DR26F9FN3.
Is contract SPE2DR26F9FN3 an order under another contract?
Yes. SPE2DR26F9FN3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9FN3 competed?
The extent of competition for SPE2DR26F9FN3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award